Preoperative Corneal Measurements Estimate the Corrected Distance Visual Acuity After Corneal Cross-linking
Could Automated Objective Measurements Acquired at the Preoperative Stage Estimate the Corrected Distance Visual Acuity After Corneal Cross-linking in Keratoconus?
1 other identifier
interventional
124
1 country
1
Brief Summary
This study aims to determine if objective markers describing corneal optical density (COD), thinnest corneal thickness (TCT), anterior (ARC), and posterior (PRC) surface radii over the 3mm thinnest region of the cornea could provide a model for calculating corrected distance visual acuity (CDVA) after corneal cross-linking (CXL) in keratoconus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2023
CompletedFirst Submitted
Initial submission to the registry
July 22, 2024
CompletedFirst Posted
Study publicly available on registry
July 26, 2024
CompletedJuly 30, 2024
July 1, 2024
4.3 years
July 22, 2024
July 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Association between preoperative corneal characteristics derived by Pentacam and subjective parameter CDVA and postoperative CDVA at the end of the follow-up period
Associations between Corneal Optical Density, Thinnest Corneal Thickness, Anterior Radius Curvature (ARC), Posterior Radius Curvature (PRC), ARC/PRC ratio, CDVA values at the start of the study and CDVA at postoperative.
one year
Associations between predicted and actual CDVA following CXL
The differences in the mean predicted values measured at six months and one year.
one year
Secondary Outcomes (3)
Corrected Distance Visual Acuity (CDVA) changes in all three groups during the follow up
one year
Corneal Optical Density (COD) changes in all three groups during the follow up
one year
Corneal thickness (TCT) changes in all three groups during the follow up.
one year
Study Arms (3)
Group 1
ACTIVE COMPARATORThe total number of patients who underwent CXL was seventy-seven; 23 were females, and 54 were males of the mean (±sd, range) age 24.2 (±7.0, 11-44) years.
Group 2
NO INTERVENTIONTwenty-three patients, six females and 17 males of mean age 27.3 (±7.0, 17-44) years, were untreated.
Group 3
NO INTERVENTIONTwenty-four subjects, nine females and 15 males of mean age 24.7 (±7.6, 17-45) years, were recruited as controls.
Interventions
Standard Dresden protocol corneal cross-linking procedure The CXL procedure adhered to the standard Dresden protocol. All patients received topical anaesthetic (Tetracaine HCL 0.5%, Alcon Forth Worth, Texas) and a miotic (Isopto Carpine 2% HCl, Alcon, Fort Worth, Texas) drops 30 minutes before the procedure. The periocular region and conjunctival sac were washed with 10% povidone-iodine (Betadine 10%, Alcaloid, Skopje). Manual epithelial scraping with a crescent knife followed. Pachymetry was kept over 400 μm during the procedure and measured with an ultrasound hand pachymeter (Pocket II, Quantel Medical, Cournon d'Auvergne, France). Riboflavin (Peschke D, Peschke Trade, Huenenberg, Switzerland) was applied every 3 minutes for 30 minutes. We performed corneal UV-A radiation with a wavelength of 370 nm and energy of 3mW using a UVA CXL lamp (VEGA CBM-X-Linker, Carleton Optical, Chesham, UK) for 30 minutes (6 cycles of 5 minutes each).
Eligibility Criteria
You may qualify if:
- Group 1 consisted of cases in which the astigmatism had increased by 1D or more, according to subjective refraction and corneal surface topography, over the previous year.
- Group 2 subjects consisted of confirmed keratoconus without signs of progression who opted to continue with their prescription glasses and tear-enhancing drops where necessary
- Group 3 is a control group of age- and gender-matched individuals without signs of keratoconus.
You may not qualify if:
- prior corneal surgeries, pachymetry less than 400 microns, scars or cloudings of the cornea, chemical injuries, severe dry eye, delayed epithelial healing and any inflammatory eye surface process before the CXL procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fanka Gilevska
Skopje, 1000, North Macedonia
Related Publications (1)
Gilevska F, Biscevic A, Bohac M, Patel S. Could Automated Objective Measurements Acquired at the Preoperative Stage Estimate the Corrected Distance Visual Acuity after Corneal Cross-Linking in Keratoconus? Ophthalmol Ther. 2024 Oct;13(10):2599-2614. doi: 10.1007/s40123-024-00993-0. Epub 2024 Aug 7.
PMID: 39110318DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fanka Gilevska, PhD cand
Sistina Ophthalmology Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 22, 2024
First Posted
July 26, 2024
Study Start
April 1, 2018
Primary Completion
July 30, 2022
Study Completion
July 30, 2023
Last Updated
July 30, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share